4.7 Article

Novel Role of Platelets in Mediating Inflammatory Responses and Ventricular Rupture or Remodeling Following Myocardial Infarction

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.110.220467

关键词

ischemic heart disease; leukocytes; platelets; thienopyridines; inflammation; myocardial infarction; ventricular rupture

资金

  1. National Health and Medical Research Council of Australia (NHMRC)

向作者/读者索取更多资源

Objective-The goal of this study was to investigate the role of platelets in systemic and cardiac inflammatory responses and the development of postinfarct ventricular complications, as well as the efficacy of antiplatelet interventions. Methods and Results-Using a mouse myocardial infarction (MI) model, we determined platelet accumulation and severity of inflammation within the infarcted myocardium by immunohistochemistry and biochemical assays, analyzed peripheral blood platelet-leukocyte conjugation using flow cytometry, and tested antiplatelet interventions, including thienopyridines and platelet depletion. Platelets accumulated within the infarcted region early post-MI and colocalized with inflammatory cells. MI evoked early increase in circulating platelet-leukocyte conjugation mediated by P-selectin/ P-selectin glycoprotein ligand-1. Antiplatelet interventions inhibited platelet-leukocyte conjugation in peripheral blood, inflammatory infiltration, content of matrix metalloproteinases or plasminogen activation, and expression of inflammatory mediators in the infarcted myocardium (all P < 0.05) and lowered rupture incidence (P < 0.01). Clopidogrel therapy alleviated the extent of chronic ventricular dilatation by serial echocardiography. Conclusion-Platelets play a pivotal role in promoting systemic and cardiac inflammatory responses post-MI. Platelets accumulate within the infarcted myocardium, contributing to regional inflammation, ventricular remodeling, and rupture. Antiplatelet therapy reduces the severity of inflammation and risk of post-MI complications, demonstrating a previously unrecognized protective action. (Arterioscler Thromb Vasc Biol. 2011;31:834-841.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis

Taide Wang, Doris Tomas, Nirma D. Perera, Brittany Cuic, Sophia Luikinga, Aida Viden, Samantha K. Barton, Catriona A. McLean, Andre L. Samson, Adam Southon, Ashley I. Bush, James M. Murphy, Bradley J. Turner

Summary: Amyotrophic lateral sclerosis (ALS) is characterized by selective degeneration of motor neurons in the brain and spinal cord, with recent findings suggesting a role for ferroptosis, an iron-dependent form of regulated cell death, in mediating motor neuron death in ALS. Depletion of the antioxidant enzyme GPX4, a central repressor of ferroptosis, was observed in post-mortem spinal cords of ALS patients and in various ALS mouse models, linking GPX4 depletion and ferroptosis to impaired NRF2 signaling and dysregulation of glutathione synthesis and iron-binding proteins. Overexpression of human GPX4 in ALS mice delayed disease onset, improved locomotor function, and prolonged lifespan, demonstrating the potential for anti-ferroptotic therapeutic strategies for ALS treatment.

CELL DEATH AND DIFFERENTIATION (2022)

Article Biochemistry & Molecular Biology

Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL

Ashish Sethi, Christopher R. Horne, Cheree Fitzgibbon, Karyn Wilde, Katherine A. Davies, Sarah E. Garnish, Annette Jacobsen, Andre L. Samson, Joanne M. Hildebrand, Ahmad Wardak, Peter E. Czabotar, Emma J. Petrie, Paul R. Gooley, James M. Murphy

Summary: Necroptosis is a programmed cell death pathway that is often deregulated in inflammatory diseases. This study identifies the membrane binding epitope of mouse MLKL and reveals differences in structure and epitope between mouse and human MLKL. These findings highlight the versatility of the 4HB domain.

CELL DEATH AND DIFFERENTIATION (2022)

Article Cell Biology

The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL

Annette Jacobsen, Catia L. Pierotti, Kym N. Lowes, Amanda E. Au, Ying Zhang, Nima Etemadi, Cheree Fitzgibbon, Wilhelmus J. A. Kersten, Andre L. Samson, Mark F. van Delft, David C. S. Huang, Helene Jousset Sabroux, Guillaume Lessene, John Silke, James M. Murphy

Summary: The Lck inhibitor AMG-47a has been identified as an inhibitor of necroptosis, particularly effective in human cells. Additionally, RIPK1 is found to play a complete dependence in cell death caused by activated MLKL, with some involvement from RIPK3.

CELL DEATH & DISEASE (2022)

Article Biochemistry & Molecular Biology

Endothelial Caspase-8 prevents fatal necroptotic hemorrhage caused by commensal bacteria

Stefanie M. Bader, Simon P. Preston, Katie Saliba, Adam Lipszyc, Zoe L. Grant, Liana Mackiewicz, Andrew Baldi, Anne Hempel, Michelle P. Clark, Thanushi Peiris, William Clow, Jan Bjelic, Michael D. Stutz, Philip Arandjelovic, Jack Teale, Fashuo Du, Leigh Coultas, James M. Murphy, Cody C. Allison, Marc Pellegrini, Andre L. Samson

Summary: Caspase-8 mediates various responses including inflammation, cell proliferation, and cell death. Its function during embryogenesis is essential for maintaining systemic circulatory system, while in adulthood it is crucial for preserving gut vascular integrity. Lack of endothelial Caspase-8 leads to fatal hemorrhagic lesions in the small intestine, resulting from aberrant microbial sensing and tumor necrosis factor receptor signaling.

CELL DEATH AND DIFFERENTIATION (2023)

Review Cell Biology

The web of death: the expanding complexity of necroptotic signaling

Christopher R. Horne, Andre L. Samson, James M. Murphy

Summary: In the past decade, the importance of the necroptosis programmed cell death pathway in the pathophysiology of various diseases has been confirmed. The receptor interacting protein kinase (RIPK)1 and RIPK3, and the pseudokinase executioner protein, mixed lineage kinase domain-like (MLKL), have emerged as core components of the pathway. These proteins also serve as integrators of signals and add complexity to pathway regulation. This article describes the emerging concept of the protein network that tunes necroptotic signal transduction and how these events have diverged across species, possibly due to selective pressures from pathogens on the RIPK3-MLKL protein pair.

TRENDS IN CELL BIOLOGY (2023)

Letter Hematology

Megakaryocyte buds are distinct from microvesicles and likely to represent platelet precursors

Marc L. Ellis, Imala Alwis, Rhyll Smythe, Yuping Yuan, Shaun P. Jackson

BLOOD ADVANCES (2023)

Article Biochemistry & Molecular Biology

MLKL deficiency protects against low-grade, sterile inflammation in aged mice

Emma C. Tovey C. Crutchfield, Sarah E. Garnish, Jessica Day, Holly Anderton, Shene Chiou, Anne Hempel, Cathrine Hall, Komal M. Patel, Pradnya Gangatirkar, Katherine R. Martin, Connie S. N. Li Wai Suen, Alexandra L. Garnham, Andrew J. Kueh, Ian P. Wicks, John Silke, Ueli Nachbur, Andre L. Samson, James M. Murphy, Joanne M. Hildebrand

Summary: MLKL and RIPK3 are core signaling proteins of the necroptosis pathway, which is involved in human disease. Necroptosis has been implicated in disease progression in multiple physiological systems and recent studies suggest its role in aging. In this study, we analyzed age-related histopathological and immunological phenotypes in Mlkl(-/-) and Ripk3(-/-) mice. We found that female Mlkl(-/-) mice showed delayed immune system aging and reduced age-related chronic sterile inflammation compared to wild-type mice. These findings suggest a possible application of anti-necroptotic therapy in age-related inflammation.

CELL DEATH AND DIFFERENTIATION (2023)

Editorial Material Surgery

Dissecting Aortas and Patient Reported Outcome Measures

Leonard L. Shan

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2023)

Meeting Abstract Surgery

Quality of Life in Chronic Limb Threatening Ischaemia: Systematic Review and Meta-Analysis

L. L. Shan, L. S. Yang, M. Tew, M. J. Westcott, T. D. Spelman, P. F. Choong, A. H. Davies

JOURNAL OF VASCULAR SURGERY (2023)

Article Surgery

Patient perspectives of quality of life in chronic limb-threatening ischemia: a qualitative study

Leonard L. Shan, Stacey Telianidis, Mark J. Westcott, Deborah Debono, Alun H. Davies, Peter F. Choong

Summary: This study conducted qualitative research and engaged patients to gain insights into the quality of life perspectives of CLTI patients. The results provide important understanding of what quality of life truly means to CLTI patients and what factors are important to their quality of life.

ANZ JOURNAL OF SURGERY (2023)

暂无数据